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Abstract. Growing and confluent cultures of a rat 
hepatocyte cell line were labeled with 35SO42- and the 
heparan sulfate in the culture medium, the pericellu- 
lar matrix, the nucleus, the nuclear outer membrane, 
and the remaining cytoplasmic pool was purified by 
DEAE-cellulose chromatography. The heparan sulfate 
in all pools from the confluent cells was bound more 
strongly on the DEAE-cellulose column than the cor- 
responding pools from the growing cells. Gel filtration 
of each pool before and after ~-elimination showed 
that the heparan sulfate from the nuclear and nuclear 
membrane pools was composed of primarily free 
chains, whereas the heparan sulfate in all of the other 
pools was a mixture of proteoglycans and free chains. 
The heparan sulfate in each pool was cleaved with 
nitrous acid to obtain mixtures of di- and tetrasaccha- 
rides. Analysis of these mixtures showed that the 
structural features of the heparan sulfates in each pool 
were different and were altered significantly when the 
growing cells became confluent. The nuclear-plus-nu- 
clear membrane pools represented 6.5% and 5.4%  of 
the total cell-associated heparan sulfate in the growing 
cells and the confluent cells, respectively. The struc- 
tural features of the heparan sulfate in the two nuclear 
pools were very similar to each other, but were mark- 
edly different from those of the heparan sulfate from 
the other pools or from any previously described hep- 
aran sulfate or heparin. The most unusual aspect of 
these structures was the high content of ~-D-glucuron- 
osyl(2-SO4)--~D-glucosamine-N,o-(SO4)2 disaccharide 
units in these sequences. The mode of biosynthesis 
and delivery of these unusual sequences to the nucleus 
and the potential significance of these observations are 
discussed. 
H 
EPARAN sulfate proteoglycan (HSPG)  ~  is a structur- 
ally variable polymer which is turned over rapidly in 
animal cells (2, 64, 68, 77). Heparan sulfate (HS) is 
structurally related to heparin, even though the core proteins 
on which the two polymers are synthesized are different (61, 
67). The biosynthesis of heparin  and HS appear to follow 
similar pathways (66, 69). Heparin is synthesized  as a polymer 
of repeating o-glucuronic acid (GlcUA)-~N-acetyl-o-glucosa- 
mine (GlcNAc) disaccharide units which then undergoes a 
series of maturation reactions initiated  by N-deacetylation, 
which occurs randomly at some of  the GlcNAc residues along 
the polymer chain, followed by N-sulfation of the resulting D- 
glucosamine (GlcN) residues. Further maturation, which oc- 
curs in the regions around the N-sulfo-D-glucosamine  (Glc- 
NSO3) residues, involves additional N-deacetylation/N-sulfa- 
tion at GIcNAc residues adjacent to the GlcNSO3 residues, 
C5 epimerization of some of the GlcUA residues to form L- 
iduronic acid (IdoUA) residues, and o-suifation of some of 
J  Abhreviatitms used in  this paper." AMan, 2,5-anhydro-D-mannose; AManR, 
2,5-anhydro-D-mannitot; CP pool, cytoplasmic pool;  GIcN,  D-glucosamine; 
GtcNAc, N-acetyI-D-glucosamine;  GIcUA, D-glucuronic acid; HPLC. high per- 
formance liquid chromatography; HS, heparan sulfate; HSPG, heparan sulfate 
proteoglycan; IdoUA, L-iduronic acid; Ma pool, matrix pool; NM pool, nuclear 
membrane pool: NUC pool, nuclear pool; TKM buffer, 0.05 M Tris, 0.025  M 
KCI, 0.005  M MgCI:. 
the GlcNAc and GIcNSO3 residues at C6 and some of the 
uronic acid residues at C2 (69). The resulting polymer con- 
tains  blocks of unsulfated  disaccharides interspersed with 
blocks of disaccharides which are sulfated to varying degrees 
(13, 48, 73). HS chains are less highly matured than heparin 
chains. Because the disaccharide units of the heparin and HS 
chains undergo different extents of maturation,  these poly- 
mers occur as mixtures of polysaccharide chains which differ 
in their sulfated disaccharide sequences and in their contents 
ofGlcUA, IdoUA, and N- and O-sulfates (16). A large portion 
of  the newly synthesized HSPG in hepatocytes is secreted into 
the extracellular matrix, then endocytosed, and catabolized 
with a hi2 of-4 h (2). Thus, the HS chains of HSPG, which 
may exhibit a relatively broad range of structures, have the 
potential  to  undergo  several significant structural  changes 
during a single cell cycle in response to the metabolic state of 
the cells. The present study shows that HS is distributed in 
several cellular compartments, including the nucleus; that the 
structural features of the HS in the different compartments 
are  different; and  that,  when  cells pass from  logarithmic 
growth to confluency, the rate of HSPG synthesis is markedly 
increased and the structures of the HS chains in the different 
cellular pools are altered. Thus, HS undergoes changes in its 
rate of  synthesis and in its structure and exhibits the potential 
to play a role in the regulation of cellular metabolism. 
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Cell Culture 
The permanent rat hepatocyte cell line (29) used previously (2) was maintained 
and  cultured  in  Higuchi's medium  (34)  containing  1%  fetal calf serum  as 
before. For labeling experiments, cells were plated at  100 cells/cm  2 in  12.5 ml 
(T-75 dishes) or 5  ml (T-25 dishes) of medium. Medium was changed at day 
4, and the cultures reached confluence after 6-7 d. Primary rat liver hepatocytes 
were cultured as described by Clancy et al. (14).  Chick embryo tibial chondro- 
cytes  from  zones  I-3  of the  tibiotarsi of  12-d  embryos  were  cultured  in 
Dulbecco's modified Eagle's medium (40. 41).  Cell densities were determined 
by removing the culture medium, washing the cells twice with 2 ml of phos- 
phate-buffered saline, releasing the cells from the dish with isotonic trypsin, 
and counting the released cells in a Coulter counter. 
Labeling and Cell Fractionation 
Alier 5 d  in culture (growing cultures) or 9 d  (confluent cultures), cells were 
labeled for  t8  h  with 25-100 uCi/ml of carrier-free H2S~SO4 (New England 
Nuclear, Boston, MA) in fresh medium. At the end of the labeling period, the 
cultures were chilled on ice and the culture medium was removed. The cells 
were rinsed twice with 2 ml of cold phosphate-buffered saline, and the washes 
were combined with the original culture medium to obtain the culture medium 
pool (CM  pool). The culture dish was then shaken at  100  rpm with 2  ml of 
0.05% trypsin (Sigma Type 111) and 0.02% EDTA in Puck's saline at 37"C for 
10 min to remove the cell layer, and the cells were transferred to a chilled 12- 
ml conical centrifuge tube. The dish was rinsed with an additional 2 ml of cold 
phosphate-buffered saline, and the cells plus wash were centrifuged in a clinical 
centrifuge for 5 min to pellet the cells. The supernatant was termed the matrix 
pool (Ma pool). All subsequent steps were performed at 4°C. The cells were 
lysed and nuclei were isolated by the method of Blobel and Potter (5).  Briefly, 
the cells were resuspended in  1.0 ml of 0.05  M  Tris, 0.025  M  KCI, 0.005  M 
MgCI2  (TKM  buffer)  with  0.25  M  sucrose  and  homogenized  in  a  Potter- 
Elvehjem-type homogenizer (20 strokes). The homogenate and a  1.0 ml rinse 
of TKM  buffer with 0.25  M  sucrose were then added to a  pre-chilled 15-ml 
polyallomar centrifuge tube. TKM buffer (4 ml) containing 2.3 M sucrose was 
then mixed with the cell homogenate. TKM  buffer (2  ml) containing 2.3  M 
sucrose was then layered through the solution to the bottom of the tube using 
an  I l-gauge needle and a crude nuclear fraction was isolated by centrifugation 
at 124,000 g for 30 min. The supernatant was termed the cytoplasmic pool (CP 
pool). The pellet was resuspended in t  ml of TKM buffer with 0.5% Triton X- 
100,  vortexed,  and  re-pelleted by  centrifugation at  800  g  for  5  min.  The 
supernatant was taken as the nuclear membrane pool (NM pool) and the pellet 
was resuspended in  1 ml of buffer X  (2) and extracted overnight at 4°C with 
shaking at  1.000  rpm.  The  supernatant  was then taken as the nuclear pool 
(NUC pool). 
For non-aqeuous isolation of nuclei, the CM and Ma pools were generated 
as  above.  The  cell  pellet was  frozen  immediately in  liquid  nitrogen  and 
lyophilized. Nuclei were isolated by the method of Kitsch et al. (42).  with all 
steps carried out at 2°C.  Cells (1  ×  10  ~) were resuspended in 0.5  ml glycerol 
and disrupted by homogenization at 20,000 rpm for 4.5 min in a motor-driven 
35  Table I.  Cellular Distribution of  S04-labeled Heparan 
Sulfate 
Cellular pool  ~ 
Growth 
Cell type  stage*  CM  Ma  CP  NM  NUC  Total 
Hepatocytes 
Cell line 
Primary 
Chondrocytes 
nmol 3sS04/106 cells 
L  1.2  0.37  0.22  0,019  0.022  1.83 
(46)  (45)  (58)  (48)  (38) 
C  1.7  1.0  2.3  0.11  0.08  5.19 
(74)  (51)  (55)  (55)  (52) 
--  1.11  0.69  0.78  0.045  0.129  2.75 
L  0.95  0.12  0.055  0.005  0.004  1.36 
* Cells in the logarithmic (L) or confluent (C) growth stage were labeled with 
SSSO,2- for  18  h  and cellular pools were isolated and analyzed for  35SO42-- 
labeled heparan sulfate. For the hepatocyte cell line, the cell doubling times 
were  12 and  t30 h,  respectively, in the L and C  growth stages. The prima~ 
hepatocytes do not divide in culture. 
* Numbers in parentheses represent the percent of the total 35SO4 in the heparan 
sulfate that was released as free s~SO4  z- by treatment with nitrous acid. 
Potter-Elvehjem homogenizer. The homogenate (2 ml) was layered over 0.5 ml 
of 85% glycerol. 15% 3-chloro-l,2-propanediol in a cellulose nitrate tube, and 
crude  nuclei were pelleted by centrifugation at  120,000 g  for  30  rain.  The 
supernatant was taken as the CP pool. The gelatinous pellet was resuspended 
in 0.1  ml glycerol with 0,5%  Triton  X-100 and pelleted at 500 g  lbr 5  min. 
The supernatant was taken as the NM pool, and the pellet as the NUC pool. 
Analysis of Chondroitin Sulfate and Heparan Sulfate 
The HS content of the labeled pools was determined by treatment of an aliquot 
of each pool with nitrous acid at pH  1.5 (72) and analysis of the products b~ 
paper chromatography lbr 24 h in n-butanol, glacial acetic acid,  I N  NH4OH 
(2:3:2) as described previously (2).  The nitrous acid treatment convened all of 
the  HS  to  oligosaccharides and  free ssSO42- which  migrated away from  the 
origin of the strip, leaving sulfated polymers at the origin. The nmol of 3~SO4 
in the HS traction spotted on the strip was calculated as the value obtained by 
dividing the total cpm of labeled ssSO4 in the migrating oligosaccharides plus 
free 3sSO4  z- by the cpm/nmol of the s~SO,2- supplied in the culture medium. 
The nmol of N-linked SO, in the HS was calculated by dividing the cpm in the 
free ssSO,fl- by the cpm/nmol of the s~SOfl- supplied in the culture medium. 
A  second aliquot of the sample was analyzed lbr chondroitin sulfate by 
treatment with a mixture of chondroitinases ABC and AC (39) to convert the 
chondroitin sulfate to disaccharides which were analyzed by paper chromatog- 
raphy for 18 h in n-butanol, glacial acetic acid, 1 M NH4OH (2:3:1). The nmol 
of s~SO4 in chondroitin sulfate on the strip were calculated by dividing the cpm 
Table II.  Effect of Cell Fractionation Procedures on 
Distribution of 35SO42--labeled Heparan Sulfate 
Cellular pool* 
Isolation procedure  CM  Ma  CP  NM  NUC  Total 
nm  ol ssSO,/10  e ¢'el/s 
Aqueous*  1.1  1.5  3.2  0.3  0.08  6.18 
Non-aqueous ~  1.1  1.7  3.0  0.08  0.25  6.13 
* Hepatocytes in the late log stage of growth were labeled for 18 h with 3sSO42- 
and the cellular pools were isolated and analyzed for the nanomoles of S~SO,- 
labeled heparan sulfate. 
* Blobel and Potter (5). 
Kirsch et al. (42). 
Table Ili.  Adventitious Binding of  HS to Nuclei* 
Labeled pool added  cpm in isolated nuclei 
(NUC +  NM Pools) 
Pool  (cpm/106 cells) ×  10  -6  Percent of added cpm ) 
l'.vperiment 1 
CP  1.5  0.23 
CP  1.6  0.40 
Experiment 2 
CM  4.0  0.15 
CM  8.0  O.O2 
CM  12.0  0.02 
Ma  1.0  0.42 
Ma  2.0  0.13 
CP  1.0  0.18 
CP  2.0  0.13 
l:\~periment 3 
[~H]heparin  0.7  0.21 
[3H]heparin  1.25  0.42 
* In  Experiment  1 nuclei from  unlabeled cells were mixed withSSSO4-1abeled 
CP pools.  In Experiments 2 and 3  unlabeled cells (2  ×  106 cells) were mixed 
with purified cellular pools (E.weriment 2) or 3H-labeled heparin (E.vperiment 
3) and  the cells were lysed and  the  NUC and  NM  pools were isolated and 
counted. The sum of the cpm in the two NUC pools was used to calculate the 
percent of the total added cpm recovered in the nuclear fraction. See text for 
details. 
All experiments were run in duplicate. Values represent averages of the two 
results obtained in each experiment. 
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Figure  1.  DEAE-cellulose  chro- 
matography of 35SO4-1abeled hep- 
aran  sulfate  from  cultured  hepa- 
tocytes. Cells were harvested dur- 
ing logarithmic growth (a and  b) 
or after reaching confluency (c and 
at)  after  labeling  with  3sso42-  for 
18  h. The CP pool (a and c) and 
the NUC pool (b and d) were iso- 
lated and fractionated  on a  DE52 
column.  In each  panel,  peak  1 is 
primarily free ~5SO4  ~-, and peak 2 
is heparan sulfate. 
in the  labeled disaccharides by the cpm/nmol  of the 35SO42- supplied in the 
culture medium. 
Isolation of  Labeled Heparan Sulfate Pools 
The HS in the CM, Ma, CP, NM. and NUC pools was purified by chromatog- 
raphy on columns of DEAE-cellulose (2). The proteoglycan nature of the HS 
was determined  by comparison  of the gel permeation  profiles before and after 
#-elimination  of the polysaccharide from the proteoglycan. For gel filtration, a 
stainless steel column (0.94 x  100 cm) packed with Fractogel TSK-HW-55(F) 
(Pierce Chemical Co.,  Rockford,  IL) and equilibrated  in 4 M guanidine-HC1 
was used for proteoglycan resolution. Chromatographic  elution was performed 
at a flow rate of  0.5 ml/min using a Perkin-Elmer Series I  0 pump. For analytical 
runs. 0.5-ml fractions were collected and taken directly for analysis by liquid 
scintillation  counting.  For preparation  of larger quantities,  1.0-ml fractions 
were collected and 0.05-ml aliquots were taken for scintillation counting. The 
fractions in peaks I, 2, and 3 from the TSK columns were combined separately, 
desalted on a BioGel P-2 column run in water, and analyzed for their content 
of HS and CS. For #-elimination,  the desalted pools were treated with alkaline 
borohydride as before (2). 
H  S for analysis of the oligosaccharide composition of each pool was isolated 
by subjecting the pool to #-elimination and treating the products with a mixture 
of chondroitinases  ABC and AC (39). The freed HS chains were recovered as 
the  void volume  material  obtained  from gel  filtration  on a TSK  HW 40(F) 
column ( 1.27 x  120 cm) developed in 0.5 M NH4 acetate and lyophilized twice 
to remove the NH, acetate (2). 
589  Fedarko and Conrad Heparan Sul[ate in Hepatoc.vte Nuclei Isolation of  Heparan Sulfate Oligosaccharides 
Formed by Nitrous Acid Cleavage 
The HS from the different pools was treated with nitrous acid at pH  1.5 (72) 
and an aliquot of the resulting mixture  of oligosaccharides was removed and 
analyzed for free 35SO42- by paper electrophoresis in 88%  formic acid/glacial 
acetic acid/water (100:348:3552) (pH 1.7) for 80 min at 25 V/cm. The remain- 
der of the reaction mixture was aldehyde-reduced with NaBH4 and separated 
according  to size by gel  filtration  on  Bio-Gel P2  (3). The  disaccharide  and 
tetrasaccharide  mixtures were then analyzed by paper electrophoresis and by 
high performance liquid chromatography  (HPLC). Paper electrophoretograms 
were run for 2 h at 25 V/cm on strips (1 x  22 in) of Whatman No. 3 paper in 
88% formic acid/glacial acetic acid/water (100:348:3552) (pH 1.7). HPLC was 
run on a 0.4  x  25 cm SAX column (Whatman Inc., Clifton, NJ) developed 
with step gradients of KH2PO4 buffers (2, 3, 17). The peaks were identified by 
comparison of their retention times with those of standards (3, 17). 
Preparation of SH-labeled Heparin 
3H-Labeled heparin  was prepared  by the  procedure  of Nakajima  et al. (59). 
Briefly, heparin (13 mg) was reacted with 2.6 mg NaBaH, (450 mCi/mmol) in 
200 #1 of 0.1  M Na borate buffer, pH 8.0, for 5 h at room temperature.  The 
reaction mixture was then acidified with 200 #1 of I N H2SO4 in the fume hood 
and separated from extraneous  3H by gel filtration on a Fractogel TSK-HW- 
40(S) column (50 x  1.1  cm) equilibrated  in 4  M guanidinium  CI.  The 3H- 
labeled material in the void volume was desalted by passage over a Fractogel 
TSK-HW-40(S) column (17 x  4.6 cm) run in 0.05 M NH4 acetate. The void 
volume  peak  was lyophilized twice to remove  the  NH4 acetate and  further 
purified by chromatography on DE52 cellulose as described for the purification 
of the cellular HS pools. 
Results 
Distribution of  SSSO,-labeled Heparan Sulfate in 
Cellular Pools 
The extracellular and intracellular pools of a hepatocyte cell 
line,  primary rat hepatocytes, and  chick  embryo chondro- 
cytes, isolated from cells cultured in the presence of 3~SO42-, 
were analyzed for 35SO4-1abeled HS. The results in Table I 
show that  all  of the  cell  types contained  HS  in  all  of the 
intracellular pools as well as in the extracellular pools. The 
largest amounts of HS were found in the extracellular pools 
and in the CP pool. Of particular note were the NUC and 
NM  pools which  together contained  from 0.3%  (chondro- 
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Figure  2.  Gel filtration analysis ofCP (a, b, e, and f) and NUC (c, d, g, and h) pools from log phase (a, c, e, and g) and confluent (b, d,f and 
h) cells.  The top panels show the TSK 55 profiles before E-elimination. The bottom panels show the corresponding fractions after r-elimination. 
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and from 8% (confluent hepatocyte cell line) to 18% (primary 
hepatocytes) of the total intracellular  pool. For the rat hepa- 
tocyte cell line, which was chosen for further study, the results 
in Table I show that the amounts of 35SO4  z- incorporated into 
the HS in all  of the cellular  pools were markedly increased 
when the cells became confluent.  In all of the pools except 
the CM pool, -50%  of the 35SO4 in the HS was released  as 
free 3sSO4  z- when the sample was treated  with nitrous acid, 
indicating that about half of the sulfate  substituents  in these 
polymers were present as N-sulfate groups on the GIcN resi- 
dues (72). 
Table II shows that essentially  the same distribution  of HS 
is found in the intracellular  fractions  when nuclei were  iso- 
lated using a non-aqueous fractionation procedure.  The only 
significant  difference  in distribution  is seen in the NM and 
NUC pools where the total HS in the two pools remains the 
same while the partitioning of the HS into the NUC pool was 
higher when the non-aqueous method was used for isolation 
of the  nuclei.  The  properties  of the  NM  and  NUC  pools 
isolated using the aqueous method were virtually identical  in 
their structural properties (below). 
Table IV.  Chromatographic  Properties of  Heparan Sulfate 
TSK 55 Chromatography 
% of 
S~SO4 in 
DEAE-  peak 
Growth  Cellulose 
Pool  stage*  position  Peak  ~  HS  CS 
Elution position 
Original  B-Eliminated 
M NH4CI  K,, 
CM  L  1.2  1 (49)  75  14  0.03  0.38 
2(11)  87  10  0.46  0.94 
3 (40)  87  9  0.97  0.97 
C  1.4  1 (69)  72  14  0.12  0.32 
2 (18)  90  6  0.41  0.94 
3 (12)  88  5  0.97  0.97 
Ma  L  1.2  1 (32)  70  20  0.03  0.26 
2 (58)  85  10  0.53  0.56 
3 (10)  90  8  0,97  0.97 
C  1.4  1 (73)  85  17  0.12  0.38 
2 (23)  78  14  0.53  0.56 
3 (4)  81  13  0.97  0.97 
CP  L  1.2  1(16)  68  18  0.21  0.53 
2 (78)  95  4  0.56  0.56 
3 (7)  95  5  0,94  0.94 
C  1.6  1 (13)  63  19  0.21  0.53 
2 (40  94  4  0.49  0.50 
3 (47)  92  5  0.94  0.94 
NM  L  1.4  1 (0) 
2 (89)  95  3  0.56  0.56 
3(11)  97  4  0.96  0.96 
C  1.9  1 (0) 
2 (97)  94  3  0.54  0.54 
3 (3)  97  4  0.96  0.96 
NUC  L  1.5  1 (0) 
2 (91)  99  2  0.56  0.56 
3 (9)  99  1  0.94  0.94 
C  2. l  1 (0) 
2 (94)  100  0  0.47  0.47 
3 (6)  99  0  0.91  0.91 
* See Table 1, footnote 1. 
: Values in parentheses are percentages of the total 
peaks 1, 2, and 3. 
s~S04 in each pool found in 
Adventitious Adsorption of Heparan Sulfate and 
Heparin to Cell Nuclei 
Three experiments were performed to determine whether the 
labeled  HS recovered in the nuclear pools was HS that was 
adsorbed  in  a  nonspecific  manner  to  the  original  nuclear 
pellets.  In these experiments, unlabeled nuclei were  isolated 
by the aqueous procedure from cultures  to which different 
labeled HS or heparin  fractions  had been added.  The results 
of these  experiments  are  shown  in  Table  III. In  the  first 
experiment, parallel cultures  were grown to the late log stage 
and one of the  cultures  was labeled  for  18  h  with  3sSO42- 
while the other was not. Both cultures were harvested at a cell 
density of 2 x  106 and crude nuclei (NUC +  NM pools) were 
separated  from the CP pools. The nuclear fraction  from the 
unlabeled culture  was mixed with the TKM-I.6  M  sucrose 
solution containing the 3~SO4-CP pool from the labeled cul- 
ture. The NUC and the NM pools were re-isolated  from the 
mixture and the total  35SO4 cpm in  the  nuclear pools was 
measured.  In the second experiment, the CM,  Ma,  and CP 
pools were  isolated  from  a  35SO4-1abeled culture  by  DE52 
chromatography and desalted by gel  filtration.  Each of the 
purified  pools  was  added  to  unlabeled  cells  from  late  log 
cultures.  The cells were lysed in  the presence  of the labeled 
pools and the NUC and NM pools were isolated and counted. 
Finally,  3H-labeled  heparin,  which had a  net charge  similar 
to that of the HS found in the nuclear HS pools, was added 
to unlabeled cells.  The cells were lysed and the nuclear pools 
were isolated and analyzed for 3H cpm. In all of these exper- 
iments, the amount of labeled HS or heparin recovered in the 
NUC-plus-NM pools was <0.5%  of the total cpm added to 
the cells or cell fraction containing the unlabeled nuclei--well 
below  the  percentage  of the  total  labeled  HS  which  was 
recovered in the nuclear fractions when the cells were labeled 
with 3sSO4  2-. 
Table  V.  Oligosaccharides  from Growing and Confluent 
Hepatocytes 
Cellular pool 
Sulfates  Growth 
Oligosaccharide  per mol*  State*  CM  Ma  CP  NM  NUC 
pmol/lO  6 cells ~ 
Disaccharides  1  L  9.0  18.0  5.6  0,5  0.7 
C  20.0  30.0  66.0  3.0  4.8 
2  L  10.0  14.0  5.0  1.8  2.4 
C  10.0  28.0  90.0  5.5  8.0 
Tetrasaccharides  1  L  16.0  6.6  6.3  1.0  0.8 
C  8.0  4.8  90.0  21.0  4.2 
2  L  1.1  0.5  1.0  1.2  0.9 
C  2.7  0.8  12.0  5.0  1.5 
3  L  1.8  0.3  0.3  0  0 
C  1.1  0.3  3.7  0  0 
4  L  0  0.I  0.2  0  0 
C  0  0.l  0.8  0  0 
Hexasaccharides  1  L  0  5.7  2.1  0  0.2 
C  0  16.0  31.0  2.7  7,2 
2  L  0  2.1  2.7  0  0.3 
C  0  2.2  20.0  7.6  0.9 
* Determined by comparison of rates of migration on paper electrophoreto- 
grams with the rates observed for standards (3); see Figs. 3 and 4. 
* See Table 1, footnote 1. 
The number of pmols of each oligosaccharide  was calculated  by dividing the 
35SO, cpm in the oligosaccharide  by the cpm/nmol of s5SO42- in the culture 
and the number of SO4 substituents on the oligosaccharide. 
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The HS from the different pools was purified first by DEAE- 
cellulose chromatography and then by gel filtration on TSK 
55 columns. The chromatographic behaviors of the HS from 
the CM and Ma pools of these cells were reported previously 
(2).  The  behaviors  of the  CP  and  NUC  pools  on  DE52 
columns and TSK 55 columns are illustrated here. The DE52 
and gel filtration elution profiles of the HS obtained from the 
CP and NUC pools of growing and confluent cells are shown 
in Figs.  1 and 2, respectively. The chromatographic behaviors 
of the HS from all pools are summarized in Table IV. Several 
features of the chromatographic behaviors of the HS in the 
different pools are of note. First, in the DE52 profiles, the HS 
in each pool is recovered exclusively in peak 2 as before (2). 
Although the HS from the CM, Ma, and CP pools of the log- 
phase cells all elute at the same position, the HS in the NM 
and NUC pools is bound more tightly and requires a higher 
concentration of NH4 acetate for elution (Table IV). Second, 
the HS from each pool of  the confluent cells was more strongly 
bound than the corresponding HS pool from the growing cells 
(Table IV and Fig.  1), indicating a change in the HS structure 
in the confluent cells. Third, on the TSK columns the HS in 
the CM,  Ma,  and CP pools of both log and confluent cells 
separated into three peaks, whereas only peaks 2 and 3 were 
obtained for the HS in the NM  and NUC pools (Table IV 
and Fig. 2). It was shown previously that most of the HS in 
proteoglycan form was present in peak 1 and this is confirmed 
in the present results by the finding that ¢/-elimination causes 
an increase in Kay of the peak 1 material (Table IV). Peak 2 
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Figure 3.  Paper electrophoretic analysis of disaccha- 
rides obtained by cleavage of heparan sulfate from the 
CP (a and c) and  NUC (b and d) with  nitrous acid. 
Heparan sulfate was isolated from log-phase (a and b) 
and  confluent  (c  and  d)  hepatocytes.  The  peaks  at 
segment 24 of the electrophoretograms migrate in the 
position of disulfated disaccharides, whereas the peaks 
at segment 15 migrate in the position of monosulfated 
disaccharides. The total cpm in each peak was used to 
calculate the nanomoles ofdisaccharide in each fraction 
(Table IV). 
segmenf  number 
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tion,  but  in  all  of the  other pools the Kay of peak 2  is not 
altered by #-elimination, indicating that these pools contain 
HS  associated  with  little  if any  core  protein.  Finally,  the 
analyses of the peaks for their HS and CS content show that 
the CS is concentrated primarily in the peak 1 material with 
smaller amounts of CS in peaks 2 and 3. The material in the 
NM and NUC pools is almost entirely HS. 
Isolation of Oligosaccharides Formed by Nitrous 
Cleavage of Heparan Sulfate 
Each purified pool of HS was treated with nitrous acid and 
the  resulting  35SO4-1abeled oligosaccharides  were  separated 
into di-, tetra-, and hexasaccharides by gel filtration (2). The 
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distribution  of each size class according to number of 804 
substituents per tool was determined by paper electrophoresis. 
This is illustrated for the di- and tetrasaccharides in Figs.  3 
and  4,  respectively. The  recoveries of each  oligosaccharide 
size and charge class are given in Table V. The results show 
that, for all pools, the sulfated oligosaccharides were recovered 
primarily in the disaccharide fraction. Approximately equal 
amounts of mono- and disulfated disaccharides were found 
in all pools except for the NM and NUC pools in which the 
amounts of disulfated disaccharides were from two- to four- 
fold greater than the amounts of monosulfated disaccharides. 
This is consistent with the stronger retention of the HS from 
these pools on the DEAE-cellulose columns (Fig.  1).  Much 
greater differences were observed for the ratios of tetra- and 
20  30 
Figure  4.  Paper electrophoretic analysis oftetrasaccha- 
rides obtained by cleavage of heparan sulfate from the 
CP (a and  c) and  NUC (b and  d)  pools with nitrous 
acid.  Heparan  sulfate was  isolated  from  log phase  (a 
and  b) and  confluent (c and  d)  hepatocytes.  Mono-, 
di-, and tri-, and tetrasulfated tetrasaccharides migrate 
at segments  14, 21, 25, and 28,  respectively. The total 
cpm in each peak was used  to estimate the nanomoles 
ofdisaccharide in each fraction (Table IV). 
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Figure 5.  HPLC  of disaccharide 
fractions obtained by cleavage of 
heparan sulfate from the CP (a and 
c) and NUC (b and d) pools with 
nitrous acid. Heparan sulfate was 
isolated from log phase (a and b) 
and  confluent (c and  d)  hepato- 
cytes. Peaks 1-7 were identified by 
comparison  of  their  retention 
times  with  those  of  standards 
(3)  as  AManR(6-SO4),  GIcUA(2- 
SO4)--*AManR,  GIcUA---~AManR- 
(6-SO4),  IdoUA---~AManR(6-SO4), 
IdoUA(  2-SO4)---~AManR, GIcUA- 
(2-SO4)--*AManR(6-SO4), and Ido- 
UA(2-SO4)---->AManR(6-SO4),  re- 
spectively. The total cpm in each 
peak was used to calculate the na- 
nomoles  of disaccharide  in  each 
fraction (Table VI). 
hexasaccharide groups in the different pools. Consistent with 
the observed increase in total HS in confluent cultures (Table 
I), the amounts of each oligosaccharide type were much higher 
in the pools obtained from confluent cells. The largest changes 
in oligosaccharide content with cell density were observed for 
the CP pool. 
HPLC Analysis of the Oligosaccharide Composition 
of the Heparan Sulfate Pools 
The  disaccharides  and  tetrasaccharides  were  analyzed  by 
HPLC. Figs.  5 and 6 show the elution profiles of the disac- 
char!des and tetrasaccharides,  respectively, of the  HS from 
the CP and  NUC pools from growing and confluent cells. 
From  these  profiles  it  is  seen  (a)  that  there  are  striking 
differences in  the  oligosaccharide  compositions of the  HS 
from these pools and (b) that the oligosaccharide composi- 
tions of the HS from these pools change with cell  density. 
The results of the HPLC analyses of the oligosaccharides from 
all of the HS pools, summarized in Table VI, show that each 
HS pool is structurally different from the other HS pools, and 
that the structure of the HS in each pool changes with cell 
density. These differences are summarized in Fig.  7,  where 
the disaccharide content of each HS pool is expressed as the 
mol percent of total disaccharides in the HS pool. 
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Figure 6.  HPLC of tetrasaccharide frac- 
tions  obtained  by  cleavage  of heparan 
sulfate from the CP (a and c) and NUC 
(b and  d) pools with nitrous acid.  Hep- 
aran sulfate was isolated from log-phase 
(a and b) and confluent (c and d) hepa- 
tocytes. Peaks were identified by compar- 
ison of their retention times with those of 
standards  (3)  (see  Table  VI).  The  total 
clam in each peak was used to calculate 
the  nanomoles  of disaccharide in  each 
fraction (Table VI). 
Discussion 
The core protein of HSPG is synthesized in the rough endo- 
plasmic reticulum and transported to the Golgi region where 
the sulfated polysaccharide chains are attached prior to secre- 
tion of the proteoglycan from the cell (69). In cultured hepa- 
tocytes, the Ma pool, but not the CM pool, is endocytosed 
and catabolized in the lysosomes (2). Catabolism of the HS is 
initiated  by  the  action  of an  endo-#-glucuronidase.  Each 
cleavage of the HS chain by this enzyme yields one fragment 
having a GIcUA residue on its reducing terminal and a second 
fragment which  must  have  a  nonreducing  terminal  GlcN 
residue (35, 43, 60, 62, 78). The specificity of the enzyme has 
not been established in terms of the N- and o-substituents on 
the newly formed nonreducing terminal GlcN residue.  The 
intracellular pool of HS consists of a mixture of the interme- 
diates in the biosynthesis of HSPG and the intermediates in 
the catabolism of HS. Consistent with these conclusions, it 
has been demonstrated that a  polyclonal antibody directed 
against the  core  protein  of HSPG binds  to  the  sinusoidal 
plasmalemmal domain on the surface of hepatocytes, to the 
cisternae of the rough endoplasmic reticulum, to the Golgi 
stack, and to endosomes and lysosomes (75). The occurrence 
of HS  (4,  56)  and  of chondroitin  sulfate (4,  22,  56,  74), 
hyaluronic acid (22,  23,  55,  73),  and other uncharacterized 
glycosaminoglycans (21, 57) in the nucleus has been reported 
previously. The antibody against the HSPG core protein did 
not  detect  nuclear  HSPG  (75).  However,  the  nuclear  HS 
observed in  the  present  study  contained  little  if any  core 
protein and therefore could not have been detected by anti- 
body binding.  In none of the previous cases where HS has 
been  found  in  isolated  nuclei  has  the  HS  structure  been 
characterized. 
Because the 35SO4 substituents of HS are concentrated in 
blocks of sulfated disaccharides which are interspersed in the 
polymer with blocks of unsulfated disaccharides (13, 48, 73), 
the structural  analysis of the  3sSO4-1abeled oligosaccharides 
formed by nitrous acid cleavage of HS gives no indication of 
lengths of the  nonsulfated  blocks of the  HS  chains  or the 
relative proportions of sulfated and nonsulfated blocks in the 
HS. However, the present study has shown significant struc- 
tural  differences  in  the  sulfated  blocks  of the  HS  in  the 
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Cellular pool 
Growth 
Oligosaccharide  stage*  CM  Ma  CP  NM  NUC 
pmol/ l O  6 cells* 
Disaccharides 
GIcU  A(  2-SO4)---~A  Manr~  L  0.64  1.70  0.50  0.03  0.04 
C  0.40  0.80  3.20  0.11  0.17 
GIcUA---~AManR(6-SO4)  L  1.10  1.40  0.70  0.07  0.12 
C  2.30  3.80  2.50  0.23  0.58 
IdoUA---~AManR(6-SO4)  L  3.20  2.50  1.30  0.07  0.08 
C  5.60  2.80  12.00  0.37  0.20 
IdoUA(2-SO4)---~AManR  L  3.40  12.00  2.60  0.13  0.23 
C  12.00  23.00  49.00  1.80  3.70 
GlcU  A(  2-SO4)---~A  ManR(6-SO4)  L  0.00  1.70  0.40  0.90  I. 10 
C  0.80  1.80  2.80  3.60  3.60 
IdoUA(2-SO4)--~AManR(6-SO4)  L  11.00  13.00  5.90  1.20  1.50 
C  8.90  29.0  92.00  2.50  2.40 
Tetrasaccharides  § 
Unknown  L  0.7  0.4  1.1  0.4  0.1 
C  1.2  1.9  33.0  1.0  0.3 
t3  I_  O.7  O.9 
C  0.3  0.1  0.8  0.5  0.4 
t4  L  0.7  0.2  O. I  O. 1 
C  0.1  0.8  3.0  0.2  0.3 
t5  L  0.8  0.2  0.3  0.0  0.0 
C  0.3  1.2  4.8  0.3  1.1 
t6  L  0.6  0.2 
C  0.5  0.3  1.4  0.1  0.6 
t7  L  0.25  0.15  0.1 
C  0.1  0.15  t.0  0.!  0.6 
t8  k  0.5  0.15  4.3 
C  0.2  0.2  1.6  0.1 
t9  L  0.17  0.03 
C  0.07  0.03  0.17  0.2 
tlO  L  0.4 
C  0.07  0.1  0.5 
t14  L  0.4 
C  0.1  0.03  0.6 
* See Table I, footnote  1. 
*  See Table V, footnote 3. 
The structures of the tetrasaccharides are given in reference 3. The structure of the unknown tetrasaccharide, which is the major tetrasaceharide peak in the CP 
pool from the confluent cells, has not been established. 
different pools as indicated by the marked differences in the 
profiles of both  the sulfated disaccharides and the sulfated 
tetrasaccharides. The NUC and NM pools, which gave very 
similar profiles, contain the  most unique HS structures. In 
fact,  the unusual structural features of the nuclear HS offer 
strong support for the conclusion from the data in Table III 
that  the  HS  found in the  nuclear fractions does  not result 
from contamination of the nuclei with HS from any of the 
other cellular pools.  When the nuclei were isolated using a 
non-aqueous method, very little HS was  found in the  NM 
pool but there was a proportionate increase in the amount of 
HS  in the  NUC  pool.  Thus, the  NM  pool  obtained when 
nuclei are isolated using aqueous procedures may be formed 
by leakage of the HS from the nuclear pool into the nuclear 
membrane. However, leakage into other cellular pools does 
not seem to  occur since HS with the structural features of 
that in the NM and NUC pool is not found in the other pools. 
The loss of proteins from the nucleus when nuclei are isolated 
by aqueous methods is well documented (63). 
The  formation  of  large  amounts  of  GlcUA(2-SO4)--* 
AManR(6-SO4) from the nuclear HS is of special note. Studies 
on the structure and the biosynthesis  of heparin have indicated 
that IdoUA is the only uronic acid in heparin that is sulfated. 
Recently, however, both GIcUA(2-SO4)--~AManR(6-SO4)  and 
GicUA(2-SO4)--*AManR have been found among the deami- 
nation products of heparin, albeit at levels which are < 1% of 
the total disaccharides formed (3). Thus, the high proportion 
of GIcUA(2-SO,)--*AManr~(6-SO4) recovered  from  the  nu- 
clear HS reflects a  very unusual species of HS.  Recently, a 
sulfatase  which  specifically cleaves the  sulfate group  from 
GlcUA(2-SO4) residues in glycosaminoglycans has been ob- 
served  in  both  human skin  fibroblasts and  chick  embryo 
chondrocytes  (71).  Curiously,  the  GIcUA(2-SO4)  sulfatase 
activities in these cell extracts were much higher than the ldo- 
UA(2-SO4) sulfatase activities in the same extracts. This sug- 
gested that 2-o-sulfated GlcUA residues in glycosaminogly- 
cans might be of greater significance  than previously believed. 
The novel presence of such a  high proportion of GIcUA(2- 
SO4) in nuclear HS may be the primary reason for the presence 
of high levels of this sulfatase. 
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Figure  7.  Distribution ofdisaccharides in cellular pools of log-phase 
(a) and confluent (b) hepatocytes. The six bars in each group of bar 
graphs  are, from  left  to  right, IdoUA(2-SO4)---~AManR(6-SO4), 
GIcUA(2-SO4)--~AManR(6-SO4), IdoUA(2-SO4)---~AManR,  GIcUA(2- 
SO4)---~AManR, GlcUA--,AManR(6-SO4), and  IdoUA---~AManR(6- 
SO4). Each bar is plotted as mol percent of the total disaccharides in 
the cellular pool. 
Another  important  aspect  of the  present  findings  is  the 
observation that both the amounts and the structural features 
of the HS in all of the pools change with cell density. Table I 
shows the marked elevation in the amount of 35SO2- incor- 
porated  into  all  of the  pools  of the  confluent  cells.  The 
chromatographic properties of  the HS chains (Fig. 1 and Table 
IV) reflect a higher degree of sulfation in the HS from con- 
fluent cultures than in that from the growing cells, presumably 
because these HS chains contain longer sequences of sulfated 
disaccharides and shorter sequences of unsulfated disaccha- 
rides than the HS from the dividing ceils. An examination of 
the disaccharide and tetrasaccharide compositions of the HS 
from growing and confluent cells shows that there is also a 
qualitative difference in the structures of the HS chains with 
changes in cell density. For the NUC pool, this difference is 
reflected  by  an  increased  percentage  of  IdoUA(2-SO4)-* 
AMana in the HS fragments in the confluent cultures and a 
decreased percentage of IdoUA(2-SO4)-*AManR(6-SO4),  with 
the percentage of GIcUA(2-SO4)-*AManR(6-SO4) remaining 
the same (Fig. 7). 
For the  most part,  the  physiological functions that  have 
been  attributed  to  HS  are  those  that  are  appropriate  for 
structures that are primarily a part of the surfaces of eukar- 
yotic cells. HS appears to play roles in (a) binding of cells to 
each  other in  vivo and  to  their growth  substratum  in  cell 
culture ( 15, 47), (b) binding oflipoprotein lipase to endothelial 
cells ( l 1),  (c) preventing blood coagulation in  capillary en- 
dothelial cells (10,  53-55), (d) filtration in glomerular base- 
ment membranes (38),  and  (e) controlling  metastasis (58). 
However, a  number of recent  observations have suggested 
that HS may play other, equally important roles in controlling 
cell growth and activity. These roles include control of the 
growth (8-10, 20, 26, 31, 36, 52), migration (52), and activities 
(50,  5 l) of smooth muscle cells, stimulation of the growth of 
vascular endothelial cells (49, 76), control of angiogenesis (25, 
27),  neutralization  of the  effects of prostacyclin on platelet 
aggregation (70), and release of growth factors from endothe- 
lial cells (49).  Most notable is the ability of heparin and HS 
to inhibit the proliferation of vascular smooth  muscle cells 
(8-10,  20,  31,  36),  an  effect which  may  be  mediated  via 
interactions of cell  surface structures either with heparin (9, 
31,  36) or a unique species of HS derived from either endo- 
thelial cells (8,  10) or smooth muscle cells (20). Also, Majack 
and  Bornstein  have shown  that  heparin  can  modulate  the 
secretory phenotype of vascular smooth muscle cells (50) and 
induce the synthesis of a unique low molecular weight colla- 
gen in these cells (51). The mechanisms of action of heparin 
and HS on smooth muscle cells are unknown. However, it is 
of note that only HS from confluent endothelial or smooth 
muscle cells will inhibit smooth muscle cell growth (10,  20). 
This implies that the HS secreted by these confluent cultures 
is a  form that is structurally different from that synthesized 
by growing cells, just as observed for all of the cellular pools 
described here. 
The origin  of the free HS chains  in  the  nucleus has not 
been established. The unique nuclear HS sequences may be 
synthesized as a  product distinct  from the  bulk of the  HS 
made  by  the  cell,  or  these  sequences  may  be  formed  as 
segments of larger HS chains. In either case, this HS presum- 
ably must be attached to the core protein during the biosyn- 
thesis in the Golgi region and then must be cleaved from the 
core protein  before entering the  nucleus.  Several pathways 
from the Golgi region to the  nucleus are possible. The HS 
may be cleaved during direct passage from the Golgi region 
to the nucleus. On the other hand, if it is formed as a segment 
of larger HS chains, it may first be secreted into the Ma pool 
(a  pool  that  contains  low  but  significant  amounts  of the 
GlcUA[2-SO4]  residues--Fig.  7)  from  which  it  is  rapidly 
endocytosed, spliced out of the longer chain, and delivered to 
the nucleus. Since the initial step in HS catabolism involves 
cleavage of the chains by the endo-/3-glucuronidase (35,  43, 
60, 61, 78), it may be that 2-o-sulfation of the GlcUA residues 
prevents the action of  this enzyme, thus, preserving sequences 
which contain GIcUA(2-SO4) residues. It is also possible that 
a cell surface receptor for the HS could bind and protect the 
unique  segments  destined  for  the  nucleus  from  catabolic 
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into  the  nucleus.  The  nuclear  HS  offers  obvious  unique 
structural features that  might  be  involved  in  binding  to a 
specific carrier protein for transport into the nucleus, includ- 
ing both the nonreducing terminal GlcN residue formed by 
the action of the endo-~-glucuronidase and the GIcUA(2-SO4) 
residues. Since the Ma pool is much larger than the NUC + 
NM pools, the differences in the overall structures of the HS 
in  the  Ma  pool  and  the  NUC  pool  do  not  preclude  the 
possibility  that  the  HS  in  the  Ma  pool  contains  short se- 
quences like those found in the nucleus. Consistent with this 
possibility,  Radoff and  Danishefsky  (65)  have  shown  that 
GlcUA and IdoUA are not evenly distributed along the chains 
of anticoagulantly active heparin. We have observed recently 
that, under labeling conditions used here, HS does not appear 
in  the  nucleus  until  2  h  after  hepatocytes  are  exposed  to 
35SO42-, long after both newly synthesized HS and endocy- 
tosed HS appear  in  the CP pool (Ishihara,  M.,  and  H.  E. 
Conrad, unpublished results).  This observation is consistent 
with the possibility that the nuclear HS is formed as a unique 
catabolite of the HSPG endocytosed from the Ma pool. It also 
demonstrates further that unlabeled nuclei can be recovered 
from cells which have accumulated significant levels of labeled 
HS in the CP pool (2). 
The nuclear localization of an HS with a structure totally 
different from those reported previously, the changes in rates 
of HSPG synthesis at confluence, the rapid turnover of HSPG 
in cells, and the structural variability of HS suggests that this 
HS species may play some unique role in regulation of cellular 
activities. Furthermore, HS appears to be ubiquitous in the 
animal  kingdom (7,  30).  The  rapid  secretion,  endocytosis, 
and catabolism of HSPG has been observed for a number of 
different cell types and appears to represent the general met- 
abolic behavior for HSPGs in all animal cells (2, 28, 64, 77). 
At present, no physiological mechanisms by which HS may 
regulate cellular functions are known. However, in nonphys- 
iological experiments, it has been shown that heparin, when 
added  to  isolated  nuclei,  stimulates both  DNA  replication 
and transcription (l,  19, 24, 44, 45), apparently by interacting 
with  the  histones  and  causing  a  physical  swelling  of the 
chromosomes and exposure of the DNA to act as template 
(6,  18,  46).  On  the  other hand,  when  these  activities  are 
assayed using a naked DNA template, heparin inhibits repli- 
cation and transcription, apparently by interacting with the 
enzymes involved in these processes. Heparin also affects the 
activities of a number of other enzymes found in the nucleus, 
including cAMP-dependent  protein kinase N  II (32), topoi- 
somerase 1 (37), and others, as well as some that are found in 
the cytoplasm of cells (12, 33). Thus, the potential for heparin- 
like structures to play a regulatory role in the activities of cells 
has been  amply demonstrated.  However, in  none of these 
cases have the in vitro effects of heparin and HS been equated 
with a physiological role for these polymers. 
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